Penny Stock to Buy #5 – AEterna Zentaris (AEZS)
Drug-development company AEterna Zentaris (NASDAQ: AEZS) specializes in oncology and endocrine therapy. AEZS is involved with every stage of product development from discovering drugs to eventually marketing them.
Since last June, this penny stock has gained 86%. More recently, AEZS is up 29% since the start of January. Looking at its last income statement, the company recently reported a quarterly revenue growth of 15%. Buy this penny stock just below its 52-week high of $2.68.